A method of in vivo treatment of cancer comprising the steps of (i) intravenously administering a radionuclide-labeled antibody, (ii) thereafter detecting tumor cells using a radionuclide activity probe, and (iii) thereafter removing the detected tumor cells by surgical excision, wherein the antibody is a humanized antibody or humanized antibody fragment according to claim 1. 24.